Opendata, web and dolomites

CONTRA SIGNED

Computational ONcology TRaining Alliance

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CONTRA project word cloud

Explore the words cloud of the CONTRA project. It provides you a very rough idea of what is the project "CONTRA" about.

data    opportunity    geographical    training    entrepreneurship    survival    treatment    train    analysing    teach    biotech    complementary    fortunately    unprecedented    successful    subsequently    huge    posed    software    modern    situation    substantial    diagnosis    begun    suffering    tumour    collectively    rectify    combination    industrial    tackle    pharmaceutical    drug    patients    insights    expertise    cancer    employments    fail    techniques    thereby    forces    struggle    lie    innovative    molecular    computational    intersection    genders    15    recruitment    consequently    assaying    scheme    initially    biology    death    sequencing    mathematical    medical    complemented    public    biomarker    last    durable    spatial    social    rendering    evolution    force    industry    evolutionary    joined    cell    components    excellent    25    heterogeneity    somatic    skills    academic    frequently    commercial    contra    single    unleash    security    nevertheless    genomic    researched    esrs   

Project "CONTRA" data sheet

The following table provides information about the project.

Coordinator
KUNGLIGA TEKNISKA HOEGSKOLAN 

Organization address
address: BRINELLVAGEN 8
city: STOCKHOLM
postcode: 100 44
website: www.kth.se

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Total cost 3˙863˙978 €
 EC max contribution 3˙863˙978 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2017
 Funding Scheme MSCA-ITN-ETN
 Starting year 2018
 Duration (year-month-day) from 2018-01-01   to  2021-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KUNGLIGA TEKNISKA HOEGSKOLAN SE (STOCKHOLM) coordinator 527˙318.00
2    KING'S COLLEGE LONDON UK (LONDON) participant 546˙575.00
3    THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE UK (CAMBRIDGE) participant 546˙575.00
4    EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH CH (ZUERICH) participant 530˙453.00
5    FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA) ES (BARCELONA) participant 495˙745.00
6    UNIVERSIDAD DE VIGO ES (VIGO PONTEVEDRA) participant 495˙745.00
7    UNIWERSYTET WARSZAWSKI PL (WARSZAWA) participant 448˙274.00
8    THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL UK (LONDON) participant 273˙287.00
9    Ardigen SA PL (Kraków) partner 0.00
10    British Columbia Cancer Agency Branch CA (Vancouver) partner 0.00
11    FUNDACION CENTRO TECNOLOXICO DE TELECOMUNICACIONS DE GALICIA ES (VIGO) partner 0.00
12    Merck KGaA DE (DARMSTADT) partner 0.00
13    Seven Bridges Genomics UK Limited UK (LONDON) partner 0.00
14    Spatial Transcriptomics AB SE (Solna) partner 0.00
15    TORUS SOFTWARE SOLUTIONS S.L. ES (A CORUNA) partner 0.00

Map

 Project objective

Cancer is a major cause of death and suffering, rendering it a huge concern to the general public. Consequently, it has been targeted by application of the molecular techniques developed during the last 20-25 years, thereby improving diagnosis and treatment. Nevertheless, although current biomarker and treatment concepts often are successful initially, they subsequently frequently fail to achieve durable drug response and long-term survival for cancer patients. The study of somatic evolution in cancer is a very promising approach to rectify this situation. Fortunately, single cell genomic sequencing has recently begun to provide opportunity to unprecedented detailed insights into tumour evolution and new techniques are emerging for assaying the spatial distribution of tumour heterogeneity. Analysing and developing methods for these emerging data sets are under-researched areas that lie at the intersection of medical, evolutionary biology, and computational research. In CONTRA, European researchers with complementary expertise have joined forces in order to collectively facilitate training of future European computational cancer researchers. We will by applying modern recruitment and selection methods in combination with offering excellent training and employments conditions, including social security, facilitate recruitment of 15 excellent ESRs, across genders and geographical areas. We will train these 15 ESRs in the mathematical, computational, and applied skills required to tackle the complex analysis problems posed by somatic evolution in cancer. We will also teach them entrepreneurship and the requirements of pharmaceutical and biotech industry. Using a novel scheme, this substantial academic cancer expertise will be complemented with industrial expertise in software development, especially for biotech and pharmaceutical industry, which will unleash key components of the innovative force of the European commercial sector in the struggle against cancer.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CONTRA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CONTRA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

DISTINCT (2019)

Dementia: Intersectorial Strategy for Training and Innovation Network for Current Technology (DISTINCT)

Read More  

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More  

DESIGN-EID (2020)

Defect Simulation and Material Growth of III-V Nanostructures- European Industrial Doctorate Program

Read More